Menu
Back to User profile » Dr Core Journal
Papers published by Dr Core Journal:
Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Louise Profit, Paul Chrisp, Carole Nadin
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome
Mark Waterlow, Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 September 2007
Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis
Louise Profit, Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 June 2007
Perindopril: the evidence of its therapeutic impact in hypertension
Andrew Thomson, Mary Greenacre
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Aprepitant: the evidence for its place in the prevention of chemotherapy-induced nausea and vomiting
Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Etanercept in psoriasis: the evidence of its therapeutic impact
Andrew Thomson
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Maraviroc: the evidence for its potential in the management of HIV
Louise Profit
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer
Sonya Haslam, Paul Chrisp
Core Evidence 2007, 2:0-0
Published Date: 15 March 2007
Bortezomib: the evidence of its clinical impact in multiple myeloma
Simon Lancaster
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
Aripiprazole: the evidence of its therapeutic impact in schizophrenia
William Winlow, Louise Profit, Paul Chrisp
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
Ciclesonide in persistent asthma: the evidence of its therapeutic value
Charlotte A. Kenreigh, Linda Timm Wagner, Paul Chrisp
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia
Louise Profit
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 30 June 2006
K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome
Margaret Duggan-Keen
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
Tigecycline: an evidence-based review of its antibacterial activity and effectiveness in complicated skin and soft tissue and intraabdominal infections
Christopher J. Dunn
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
Joanne Knowles
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value
Andrew Thomson
Core Evidence 2006, 1-Issues 3 & 4:0-0
Published Date: 31 March 2006
Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction
Carole Nadin
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia
Andrew Thomson
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Topiramate: the evidence for its therapeutic value in the prevention of migraine
Carole Nadin
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Exubera® (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes
Louise Profit
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Lapatinib: the evidence for its therapeutic value in metastatic breast cancer
Andrew Thomson
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 30 June 2005
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
Andrew Thomson
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 31 March 2005
Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
Carole Nadin
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 31 March 2005
Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes
William Winlow
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 31 March 2005
Aliskiren in hypertension: evidence for its potential therapeutic value
Doris Peter
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 31 March 2005
Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia
Sonya Haslam
Core Evidence 2005, 1-Issues 1 & 2:0-0
Published Date: 31 March 2005